Bharatt Chowrira Acquires 167,739 Shares of PureTech Health plc (LON:PRTC) Stock

PureTech Health plc (LON:PRTC) insider Bharatt Chowrira bought 167,739 shares of the firm’s stock in a transaction dated Thursday, July 3rd. The shares were acquired at an average price of GBX 1 ($0.01) per share, for a total transaction of £1,677.39 ($2,289.33).

PureTech Health Stock Performance

PureTech Health stock opened at GBX 129.40 ($1.77) on Friday. The stock has a 50-day simple moving average of GBX 131.52 and a 200 day simple moving average of GBX 136.29. The stock has a market capitalization of £388.69 million, a price-to-earnings ratio of -5.31 and a beta of 1.02. The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. PureTech Health plc has a 12-month low of GBX 100.40 ($1.37) and a 12-month high of GBX 192 ($2.62).

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.